Updates are available Correction dated 2020-09-07
Click to view Correction: https://doi.org/10.1186/s13023-020-01447-z
-
Authors
Welsink-Karssies, Mendy M.
Oostrom, Kim J.
Hermans, Merel E.
Hollak, Carla E. M.
Janssen, Mirian C. H.
Langendonk, Janneke G.
Oussoren, Esmee
Rubio Gozalbo, M. Estela
de Vries, Maaike
Geurtsen, Gert J.
Bosch, Annet M. https://orcid.org/0000-0001-5027-5916
- License Information
-
More Information
Article History
Received: 18 October 2019
Accepted: 5 December 2019
First Online: 7 February 2020
Change Date: 7 September 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via the original article.
Ethics approval and consent to participate
: The local medical ethics committee gave waivers for both the data collection of the neuropsychological assessment and the Social Responsiveness (SRS) questionnaire (reference number METC W18_100 # 18.128).All included patients, their parents or legal representatives gave informed consent for the use of clinical data for research purposes.
: Not applicable.
: Mendy M. Welsink-Karssies, Kim J. Oostrom, Merel E. Hermans, Mirian C.H. Janssen, Janneke G. Langendonk, Esmee Oussoren, M. Estela Rubio Gozalbo, Maaike de Vries and Gert J. Geurtsen declare they have no conflict of interest. Carla E.M. Hollak is involved in premarketing studies with Sanofi, Protalix and Idorsia in the field of lysosomal storage disorders. She reports no conflicts of interest in relation to the current study. Annet M. Bosch received a speakers fee from Nutricia and was member of an advisory board of Biomarin.
